Back to Journals » Drug Design, Development and Therapy
Drug Design, Development and Therapy
Editor-in-Chief: Professor Frank Boeckler
An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (5660)
- Volume 20, 2026 (428)
- Volume 19, 2025 (762)
- Volume 18, 2024 (430)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Latest articles:
- 5 records -
Discharge Readiness After Propofol with or without Esketamine for Flexible Bronchoscopy: A Randomized Non-Inferiority Trial
Zhang X, Chen L, Chen Z, Yang J, Zheng T, Lin W, Guan J, Yao Y
Drug Design, Development and Therapy 2026, 20:612153
Published Date: 22 June 2026
Enhanced Recovery and Postoperative Analgesia After Laparoscopic Myomectomy: A Randomized Controlled Trial Comparing Total Intravenous Anesthesia, Transversus Abdominis Plane Block with Rectus Sheath Block, and Quadratus Lumborum Block
Zeng C, Ling G, Huang C, Pan T, Tang Y, Kong F, Dai L, Xiao W, Liang Y, Gong Z
Drug Design, Development and Therapy 2026, 20:622304
Published Date: 22 June 2026
Population Pharmacokinetics and Dose Optimization of Vancomycin in Adult Cancer Patients
Gao J, Gao X, Xu Y, Feng Z, Wang P, Gong W, Wang M
Drug Design, Development and Therapy 2026, 20:608206
Published Date: 20 June 2026
Molecular Mechanisms Underlying the Anti-Diabetic Effects of Astragaloside IV: A Focus on Signaling Pathways
Chen C, He P, Liu Y, Ma J, Zhai H, Yu R
Drug Design, Development and Therapy 2026, 20:600460
Published Date: 20 June 2026
From Phytochemistry to Drug Discovery: A Systematic Review of Multitarget Pharmacology and Lead Compound Prioritization of Piper crocatum Ruiz & Pav
Apriyanti E, Kurnia D, Al-Anshori J, Takaya A
Drug Design, Development and Therapy 2026, 20:611626
Published Date: 20 June 2026